SIRION Biotech
is a Germany-based company that designs and supplies viral vectors for genetic cell modeling, target validation, and preclinical development... Read moreSIRION Biotech
is a Germany-based company that designs and supplies viral vectors for genetic cell modeling, target validation, and preclinical development... Read more
News
Feb 16, 2022
Business Wire
Press Release: SIRION Biotech : PerkinElmer's SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy
Sep 17, 2021
Global Legal Chronicle
SIRION: PerkinElmer, Inc.'s Acquisition Of Sirion Biotech
Jun 29, 2021
Contract Pharma
SIRION: PerkinElmer to Acquire Sirion Biotech
Jun 25, 2021
Global Legal Chronicle
SIRION: PerkinElmer, Inc.'s Acquisition Of SIRION BIOTECH GmbH
Jun 24, 2021
News-Medical
SIRION: PerkinElmer to buy SIRION Biotech
Mar 11, 2021
StreetInsider
Press Release: Sirion-Biotech : SIRION Biotech Hosts "Engineering AAV Lead Vectors for Gene Therapy" Webinar on March 16 at 9 a.m. EST/3 p.m. CET
Feb 24, 2021
PharmaTimes
Sirion-Biotech: Sanofi partners with SIRION to improve AAV capsids for gene therapy treatments
Jan 07, 2021
FinanzNachrichten
Sirion-Biotech: SIRION Biotech GmbH Licensed Its LentiBOOST Transduction Technology to Cellectis
Jul 14, 2020
Drug Genius
Sirion-Biotech: Munich and Boston-Based Viral Vector Pioneer Achieves 26% Growth for H1 2020 Despite COVID-19 Pandemic
Apr 16, 2020
PRWeb
Press Release: Sirion-Biotech : SIRION Biotech to Present at April 2020 Virtual Investor Summit: Company to present update on support of its COVID-19 project using its viral vector platforms
SIRION Biotech Competitors
1
2
3
4
5
6
7
8
9
10